Just – Evotec Biologics announces product development and manufacturing agreement with OncoResponse

  • Evotec SE today announced that its wholly-owned Seattle-based subsidiary company Just – Evotec Biologics, Inc. has established a collaborative relationship with OncoResponse, Inc., a biotech company developing human antibodies as product candidates for multiple high value targets associated with immunosuppressive myeloid biology. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/just—evotec-biologics-announces-product-development-and-manufacturing-agreement-with-oncoresponse-5899

    Du magst vielleicht auch